The stock ended at Rs 268 - up 2.3%. The counter witnessed comparatively heavy volumes of around 422,550 shares on the BSE today.
___________________________________________________
(Updated at 1328hrs)
Cipla today rallied to a 52-week high of Rs 270 ahead of its Q1 results this Wednesday. The stock has now advanced 2.5% to Rs 268.
The counter has witnessed trades of 306,525 shares, which is significantly more than its two-week average traded volume of 226,500 shares on the BSE.
Recently, Cipla received demand notices from the Supreme Court. The company has been slapped with a fine of Rs 64.39 crore and Rs 2.19 crore in respect of the drug Salbutamol and Norfloxacin by the National Pharmaceutical Pricing Authority, Government of India.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app